These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10500812)

  • 1. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells.
    Belhoussine R; Morjani H; Gillet R; Palissot V; Manfait M
    Adv Exp Med Biol; 1999; 457():365-81. PubMed ID: 10500812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
    Perkins C; Kim CN; Fang G; Bhalla KN
    Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities.
    Côme MG; Bettaieb A; Skladanowski A; Larsen AK; Laurent G
    Int J Cancer; 1999 May; 81(4):580-7. PubMed ID: 10225448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
    Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T
    Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
    Wu CH; Rastegar M; Gordon J; Safa AR
    Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.
    Amarante-Mendes GP; McGahon AJ; Nishioka WK; Afar DE; Witte ON; Green DR
    Oncogene; 1998 Mar; 16(11):1383-90. PubMed ID: 9525737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to apoptosis induced by topoisomerase I inhibitors in multidrug-resistant HL60 leukemic cells.
    Palissot V; Belhoussine R; Carpentier Y; Sebille S; Morjani H; Manfait M; Dufer J
    Biochem Biophys Res Commun; 1998 Apr; 245(3):918-22. PubMed ID: 9588215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.
    Allouche M; Bettaieb A; Vindis C; Rousse A; Grignon C; Laurent G
    Oncogene; 1997 Apr; 14(15):1837-45. PubMed ID: 9150390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the anti-apoptotic effects of Bcr-Abl, Bcl-2 and Bcl-x(L) following diverse apoptogenic stimuli.
    Brumatti G; Weinlich R; Chehab CF; Yon M; Amarante-Mendes GP
    FEBS Lett; 2003 Apr; 541(1-3):57-63. PubMed ID: 12706819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).
    Notarbartolo M; Cervello M; Dusonchet L; Cusimano A; D'Alessandro N
    Cancer Lett; 2002 Jun; 180(1):91-101. PubMed ID: 11911975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines.
    Jakubikova J; Bao Y; Sedlak J
    Anticancer Res; 2005; 25(5):3375-86. PubMed ID: 16101152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
    Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From molecular characteristics to cellular events in apoptosis-resistant HL-60 cells.
    Palissot V; Morjani H; Belloc F; Cotteret S; Dufer J; Berchem G
    Int J Oncol; 2005 Mar; 26(3):825-34. PubMed ID: 15703842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571.
    Tabrizi R; Mahon FX; Cony Makhoul P; Lagarde V; Lacombe F; Berthaud P; Melo JV; Reiffers J; Belloc F
    Leukemia; 2002 Jun; 16(6):1154-9. PubMed ID: 12040447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors contributing to the resistance to apoptosis induced by topoisomerase I inhibitors in vincristine resistant cells.
    Palissot V; Trussardi A; Gorisse MC; Dufer J
    Adv Exp Med Biol; 1999; 457():355-63. PubMed ID: 10500811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
    Ohi Y; Kim R; Toge T
    Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.